Mergers & Acquisitions

Brennan Investment Group Announces Redevelopment Project In Austin, Texas

Brennan Investment Group Announces Redevelopment Project In Austin, Texas Acquisition expands Texas region portfolio to 28 buildings PR Newswire CHICAGO, Feb. 29, 2016 CHICAGO , Feb. 29, 2016 /PRNewswire/ — Brennan Investment Group, LLC, a private real estate investment firm that acquires, develops and operates industrial properties on a national basis, has purchased a 200,411 square foot vacant industrial facility previously occupied by Sysco Foods. […]

Mergers & Acquisitions

Burson-Marsteller Joins Forces with Sports Specialists TSE Consulting

Burson-Marsteller Joins Forces with Sports Specialists TSE Consulting PR Newswire BRUSSELS, Feb. 29, 2016 BRUSSELS , Feb. 29, 2016 /PRNewswire-USNewswire/ — Burson-Marsteller, a leading global strategic communications and public relations firm, announced today it has acquired a majority stake in TSE Consulting, an international sports consulting firm. […]

Stock Analysts

Ericsson Inks Network Enhancement Contract for Telenor Asia

Wireless equipment company Ericsson ERIC has inked a five-year network enhancement contract with Telenor Group. The contract covers the design and implementation of 4G/LTE networks, along with the transformation of 2G and 3G networks in Thailand, Myanmar and Bangladesh. Under the contract, Ericsson will install the RBS 6000 — its multi-standard radio base station which supports 3G and 4G/LTE in a single cabinet […]

Stock Analysts

Science Applications (SAIC) Wins Contract from U.S. Army

Science Applications International Corporation SAIC , a leading technology integrator, recently secured a contract from the U.S army to provide logistics support services to the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD). SAIC is one of a total of Array7 awardees for the indefinite delivery, indefinite quantity contract valued at a total of $900 million. […]

Stock Analysts

Dow Extends Research Agreement with Radiant Genomics

The Dow Chemical Company ’s DOW fully-owned subsidiary, Dow AgroSciences, recently announced the expansion of a research agreement with Radiant Genomics. The agreement had been signed in mid-20Array5. This alliance brings together the patent metagenomic and engineering-biology technologies from Radiant Genomics and the industry-leading natural products discovery and product development potential of Dow AgroSciences to offer naturally-derived products […]

Stock Analysts

Lamar Advertising (LAMR) Unveils 8.7% Increase in Dividend

Delighting its shareholders, Lamar Advertising Company LAMR declared a quarterly cash dividend of 75 cents per share, reflecting a hike of 8.7% form the prior dividend of 69 cents. The increased dividend will be paid on Mar 3Array, to shareholders of the company’s class A and class B common stock as of Mar Array6. According to the new dividend rate, annualized yield comes to around 5.38%, considering Lamar’s closing price of $55.78 on Feb 25 […]

Stock Analysts

United Therapeutics Tops on 4Q Revenues, Earnings Up Y/Y

United Therapeutics Corporation UTHR reported fourth quarter earnings of $3.68 per share (excluding stock-based compensation expense), up 30% from the year-ago period. The Zacks Consensus Estimate for fourth quarter 20Array5 earnings was $2.57 per share. Including stock-based compensation expense, earnings were $2.2Array per share. […]

Stock Analysts

Alkermes Q4 Loss Narrower than Expected, Updates Pipeline

Alkermes plc ALKS reported a loss of 30 cents per share (including share-based compensation expense) in the fourth quarter of 20Array5, narrower than the Zacks Consensus Estimate of a loss of 39 cents. The company had reported earnings of 2 cents per share in the year-ago quarter. Alkermes reported revenues of $Array63.Array million for the fourth quarter of 20Array5, down 6.9% from the year-ago quarter, which included products sales from the divested Gainesville manufacturing facility […]

Stock Analysts

Aegerion Q4 Loss Narrower than Expected, Pipeline in Focus

Aegerion Pharmaceuticals, Inc. AEGR reported a loss of 89 cents per share in the fourth quarter of 20Array5, much wider than the year-ago loss of Array2 cents per share but narrower than the Zacks Consensus Estimate of a loss of 97 cents. In the reported quarter, net product sales were $49.0 million, in line with the Zacks Consensus Estimate but down 5.2% year over year […]